Simultaneously, the Kaplan-Meier analysis showed that lowered expression of ITM2A exhibits poor outcomes in breast cancer patients (Fig. 1g and h; Additional file 1: Figure S1 A-L). This evidence concerns the gene ITM2A and breast carcinoma.